share_log

常山药业(300255.SZ):艾本那肽原料药车间和制剂车间均已建设完成,获批后可投入商业化生产

Hebei Changshan Biochemical Pharmaceutical (300255.SZ): The abemaciclib active pharmaceutical ingredient workshop and formulation workshop have been completed, and can be put into commercial production after approval.

Gelonghui Finance ·  Nov 1 02:52

On November 1, Changshan Pharmaceutical (300255.SZ) stated on the investor interaction platform that abenpeptide is currently in the evaluation stage of pharmaceutical regulatory authorities and has not yet obtained marketing approval. The company's abenpeptide active pharmaceutical ingredient workshop and formulation workshop have been completed, and can be put into commercial production after approval, with preparations for sales after approval already underway, including team building, marketing strategy, etc.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment